Skip to main content
. 2022 Dec 12;8(2):e002412. doi: 10.1136/rmdopen-2022-002412

Figure 1.

Figure 1

Study design. A total of 223 patients in the RA MTX cohort, 323 in the RA non-MTX cohort and 1690 in the non-RA cohort achieve pregnancy during the follow-up period. The proportion of days covered by MTX treatment was calculated by dividing the milligrams of active substance purchased by the subject by the defined daily dose (DDD) and then by the follow-up period before pregnancy. MTX, methotrexate; RA, rheumatoid arthritis; PDC, proportion of days covered.